Vita Reed covers healthcare, including health insurance, hospitals, medical devices and drug companies for the Orange County Business Journal. She can be reached at reed@ocbj.com.
Recent Stories
Ista Doesn’t Budge; More Suitors Seen
HEALTHCARE: Rejects second Valeant offer over deadline
Ista Pharmaceuticals Inc. doesn’t budge on offer from Valeant, more suitors seen
Allergan Hikes R&D, Reviews Wish List
HEALTHCARE: “More shots on goal” for potential acquisitions
Allergan Inc. plans to boost spending and eye possible acquisitions to reload its product pipeline this year
Edwards Goes With Cautious Expectations for Year
HEALTHCARE: Positive news on bid for new approach on Sapien
Heart-valve maker Edwards Lifesciences Corp. sets out cautious expectations for this year after busy 2011
ICU Medical Touted as Attractive Buyout Candidate
Motley Fool Pundit Floats Hospira as Good-Fit Buyer
Some industry watchers see ICU Medical Inc. in San Clemente as an appealing takeover candidate, in Healthcare
Edwards Beats Expectation on Profits, Misses on Revenue, Reaffirms Guidance
Irvine-based heart valve maker Edwards Lifesciences Corp. today posted mixed fourth-quarter results and gave conservative guidance for the current quarter and the full year.
Allergan in Line on Quarterly Profit, Revenues
Irvine’s Allergan Inc. today reported fourth-quarter financial results in line with expectations and provided measured guidance for the current quarter and 2012.
Positive Clinical Trial Results Send Edwards Lifesciences Up
Irvine-based heart valve maker Edwards Lifesciences Corp.'s shares rose today on positive test results for its new less-invasive valve.
CorVel Shares Fall on Lower Profits
Shares of CorVel Corp., an Irvine healthcare services company, fell today on financial results that missed expectations.
Valeant Withdraws $360 Million Offer for Ista
Valeant Pharmaceuticals International of Canada said today that it was pulling its takeover bid for Irvine-based eye drug maker Ista Pharmaceuticals Inc. because of a lack of progress in talks.
Questcor Critic Had Short Position
Anaheim Drug Maker Fires Back
Questcor critic had short position, Anaheim drug maker fires back
